These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1011739)

  • 21. [Clinico-radiological observations and biological studies in patients with pulmonary tuberculosis treated with prothionamide].
    Lenci E; Perko V; Falaschi C
    G Pneumol; 1970 Dec; 14(4):249-63. PubMed ID: 5526261
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical trial of combined prothionamide-ethambutol in treatment of common pulmonary tuberculosis (40 cases)].
    Miguères J; Jover A; Garbarini A
    Rev Tuberc Pneumol (Paris); 1970; 34(1):184-92. PubMed ID: 5517739
    [No Abstract]   [Full Text] [Related]  

  • 23. [Concentration of ethionamide and prothionamide in the blood of patients with pulmonary tuberculosis].
    Bialik IB; Kalabukha AV
    Vrach Delo; 1973 Nov; 11():97-100. PubMed ID: 4206857
    [No Abstract]   [Full Text] [Related]  

  • 24. Duration of allergy to antituberculous drugs (PAS, SM and INH) in tuberculous patients.
    Brown H; Jennings TS; Coleman EO; Bulubash V
    Med Ann Dist Columbia; 1966 Dec; 35(12):652-7 passim. PubMed ID: 5231829
    [No Abstract]   [Full Text] [Related]  

  • 25. [Bacteriostatic activity of blood in single and combined use of ethionamide or prothionamide].
    Kozulitsyna TI; Korotaev GA
    Probl Tuberk; 1975; (5):70-3. PubMed ID: 1144350
    [No Abstract]   [Full Text] [Related]  

  • 26. [Isoniazio, prothionamide and diafenylsulphone (isoprodian) in the therapy of previously untreated pulmonary (author's transl)].
    Müller W
    Prax Pneumol; 1976 Mar; 30(3):157-64. PubMed ID: 785434
    [No Abstract]   [Full Text] [Related]  

  • 27. [Short- and long-term results of tuberculosis therapy with a fixed combination of isoniazide, prothionamide and diaminodiphenylsulfone combined with rifampicin].
    Hoose C; Eberhardt K; Hartmann W; Wosniok W
    Pneumologie; 1990 Feb; 44 Suppl 1():458-9. PubMed ID: 2114630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the toxicity of prothionamide and ethionamide: a report from the research committee of the British Tuberculosis Association.
    Tubercle; 1968 Jun; 49(2):125-35. PubMed ID: 5243159
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative study (tolerance and effectiveness) of classic antituberculous therapy (P.A.S.-streptomycin-isoniazid) and a new combination (prothionamide-streptomycin-isoniazid)].
    Charpin J; Taranger J; Boutin C; Girbal JP
    Mars Med; 1969; 106(11):895-7. PubMed ID: 5407168
    [No Abstract]   [Full Text] [Related]  

  • 30. [Uric lithiasis in the remaining kidney after nephrectomy and treatment by rifampicin and prothionamide in a patient with renal tuberculosis].
    Motz C; Adjiman M; Polacco J; Thomas J
    J Urol Nephrol (Paris); 1974; 80(1):190-2. PubMed ID: 4841745
    [No Abstract]   [Full Text] [Related]  

  • 31. Prothionamide and dapsone therapy in leprosy--a clinical study.
    Kundu SK; Hazra SK; Chaudhury SK; Chatterjee B
    Indian J Lepr; 1985; 57(1):90-6. PubMed ID: 3839829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative studies of adverse effects of 1314TH and 1321TH 2].
    Gomi J; Aoyagi T; Oana M; Kawai T; Yamada Y
    Saishin Igaku; 1970 Dec; 25(12):2569-75. PubMed ID: 4923131
    [No Abstract]   [Full Text] [Related]  

  • 33. [Haematological effects of isoprodian (author's transl)].
    Peters M; Papageogiou A
    Prax Pneumol; 1976 Jul; 30(7):430-4. PubMed ID: 967820
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug intolerance and depressive states in tubercular patients].
    Scherding JP; Suerinck E
    Rev Tuberc Pneumol (Paris); 1967; 31(1):55-60. PubMed ID: 6037247
    [No Abstract]   [Full Text] [Related]  

  • 35. [Local application of corticosteroids in aimed treatment of pulmonary tuberculosis].
    Arch F
    Med Monatsschr; 1972 Jan; 26(1):32-6. PubMed ID: 5022581
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical study of Th 1321 tolerance in the course of pulmonary tuberculosis].
    Brun J; Revol A; Moulinier J; Queneau P
    Mars Med; 1966; 103(11):795-9. PubMed ID: 5991811
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effectiveness of prolonged antibacterial therapy in newly detected patients with active pulmonary tuberculosis].
    Kuropatkin IF; Chuprova KP
    Probl Tuberk; 1967; 45(9):32-5. PubMed ID: 5606475
    [No Abstract]   [Full Text] [Related]  

  • 38. [Severe hypoprothrombinemia in a tubercular patient treated by combined rifampicin, isoniazid, streptomycin and prothionamide].
    Hinaut G; Bosio AM; Estampes B
    Rev Tuberc Pneumol (Paris); 1970 Mar; 34(2):291-5. PubMed ID: 5510315
    [No Abstract]   [Full Text] [Related]  

  • 39. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.
    Pattyn SR; Portaels F; Van Loo G; Van den Breen L
    Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [On the polymorphism of drugs: medrogestone, phensuximide and protionamide (author's transl)].
    Kuhnert-Brandstätter M; Bösch L
    Arch Pharm (Weinheim); 1978 Sep; 311(9):757-61. PubMed ID: 708206
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.